Humana Inc. (LON:0J6Z)
London · Delayed Price · Currency is GBP · Price in USD 179.52
+1.52 (0.85%)
At close: Feb 12, 2026
Humana Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Premiums & Annuity Revenue | 122,825 | 112,104 | 101,272 | 87,712 | 79,822 |
Total Interest & Dividend Income | 1,006 | 1,202 | 1,123 | 587 | 317 |
Gain (Loss) on Sale of Investments | - | 24 | -54 | -205 | -130 |
Other Revenue | 5,833 | 4,431 | 4,033 | 4,776 | 3,055 |
| 129,664 | 117,761 | 106,374 | 92,870 | 83,064 | |
Revenue Growth (YoY) | 10.11% | 10.71% | 14.54% | 11.80% | 7.66% |
Policy Benefits | 110,812 | 100,664 | 88,394 | 75,690 | 69,199 |
Depreciation & Amortization | 698 | 839 | 779 | 709 | 596 |
Selling, General & Administrative | 15,450 | 13,215 | 12,591 | 12,198 | 10,121 |
Total Operating Expenses | 126,960 | 114,718 | 101,764 | 88,597 | 79,916 |
Operating Income | 2,704 | 3,043 | 4,610 | 4,273 | 3,148 |
Interest Expense | -631 | -660 | -493 | -401 | -326 |
Earnings From Equity Investments | -102 | -94 | -63 | -4 | 65 |
Other Non Operating Income (Expenses) | -451 | -181 | -137 | -68 | 532 |
EBT Excluding Unusual Items | 1,520 | 2,108 | 3,917 | 3,800 | 3,419 |
Merger & Restructuring Charges | - | -281 | -506 | -473 | - |
Gain (Loss) on Sale of Assets | -67 | - | - | 237 | - |
Asset Writedown | - | -200 | -91 | - | - |
Pretax Income | 1,453 | 1,627 | 3,320 | 3,564 | 3,419 |
Income Tax Expense | 250 | 413 | 836 | 762 | 485 |
Earnings From Continuing Ops. | 1,203 | 1,214 | 2,484 | 2,802 | 2,934 |
Minority Interest in Earnings | -15 | -7 | 5 | 4 | -1 |
Net Income | 1,188 | 1,207 | 2,489 | 2,806 | 2,933 |
Net Income to Common | 1,188 | 1,207 | 2,489 | 2,806 | 2,933 |
Net Income Growth | -1.57% | -51.51% | -11.30% | -4.33% | -12.89% |
Shares Outstanding (Basic) | 120 | 121 | 124 | 126 | 129 |
Shares Outstanding (Diluted) | 121 | 121 | 124 | 127 | 129 |
Shares Change (YoY) | -0.04% | -2.87% | -2.09% | -1.78% | -2.72% |
EPS (Basic) | 9.86 | 10.01 | 20.09 | 22.20 | 22.79 |
EPS (Diluted) | 9.84 | 9.98 | 20.00 | 22.08 | 22.67 |
EPS Growth | -1.40% | -50.10% | -9.42% | -2.60% | -10.43% |
Free Cash Flow | 375 | 2,391 | 2,977 | 3,450 | 920 |
Free Cash Flow Per Share | 3.10 | 19.78 | 23.92 | 27.14 | 7.11 |
Dividend Per Share | 3.540 | 3.540 | 3.540 | 3.150 | 2.800 |
Dividend Growth | - | - | 12.38% | 12.50% | 12.00% |
Operating Margin | 2.08% | 2.58% | 4.33% | 4.60% | 3.79% |
Profit Margin | 0.92% | 1.03% | 2.34% | 3.02% | 3.53% |
Free Cash Flow Margin | 0.29% | 2.03% | 2.80% | 3.72% | 1.11% |
EBITDA | 3,528 | 3,351 | 4,938 | 4,593 | 3,418 |
EBITDA Margin | 2.72% | 2.84% | 4.64% | 4.95% | 4.12% |
D&A For EBITDA | 824 | 308 | 328 | 320 | 270 |
EBIT | 2,704 | 3,043 | 4,610 | 4,273 | 3,148 |
EBIT Margin | 2.08% | 2.58% | 4.33% | 4.60% | 3.79% |
Effective Tax Rate | 17.21% | 25.38% | 25.18% | 21.38% | 14.19% |
Revenue as Reported | 129,664 | 117,761 | 106,374 | 92,870 | 83,064 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.